NSCLC showed the largest reduction in metastatic progression with GLP-1RAs versus gliptins (HR 0.50), with significant ...

The discovery challenges the long-standing idea that early humans mainly evolved and survived in open grasslands, coasts, or ...

UH engineers helped develop an mRNA-based strategy that boosts cancer-fighting T cells and, in mouse studies, helped ...

Emerging growth opportunities in the next-generation immune checkpoint inhibitors market include the development of therapies targeting novel immune pathways employed to tackle cancer resistance ...

Using artificial intelligence (AI) to specialize treatment for patients with different kinds of cancer can be a boon to clinicians looking to personalize their care. Pathways have become critical in ...

Evexomostat combination shows clinical benefit and favorable safety in heavily pretreated HR+/HER2− mBC patients with ...

Why do two people with the same cancer diagnosis—the same stage, the same cell type, and the same clinical profile—often have ...

Dynamic clinical pathways are essential to keep pace with rapid advancements in oncology treatments and FDA approvals. Inclusive participation and effective communication are vital for pathway ...

SEATTLE — Since 2005, Cancer Pathways has been going into as many school classrooms to share life-saving information. Cancer Pathways, formerly Gilda's Club Seattle, has made it a goal to reach as ...